Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer

Annals of the New York Academy of Sciences

Volumn 1137, Issue , 2008, Pages 98-107

  Board, Ruth E ^a,b,c   Williams, Victoria S ^a   Knight, Lucy ^a   Shaw, Jacqueline ^d   Greystoke, Alastair ^b,c   Ranson, Malcolm ^b   Dive, Caroline ^c   Blackhall, Fiona H ^b   Hughes, Andrew ^a  

^a ASTRAZENECA   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Circulating DNA; Fragment sizes; Small cell lung cancer

Indexed keywords

DNA; DNA FRAGMENT;

ADULT; AGED; ANALYTIC METHOD; CONFERENCE PAPER; CONTROLLED STUDY; DNA EXTRACTION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MALE; POLYMERASE CHAIN REACTION;

EID: 52249121583     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1448.020     Document Type: Conference Paper

References (25)

1. Shapiro, B. et al. 1983. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51 : 2116 2120.
2. Shinozaki, M. et al. 2007. Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy. Clin. Cancer Res. 13 : 2068 2074.
3. Kimura, H et al. 2006. Detection of epidermal growth factor receptor mutations in serum as a predictor of the response to gefitinib in patients with non-small-cell lung cancer. Clin. Cancer Res. 12 : 3915 21.
4. Anker, P. et al. 1997. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112 : 1114 1120.
5. Esteller, M. et al. 1999. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res. 59 : 67 70.
6. Wong, I.H. et al. 1999. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res. 59 : 71 73.
7. Hoque, M.O. et al. 2006. Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer. J. Clin. Oncol. 24 : 4262 4269.
8. Umetani, N. et al. 2006. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J. Clin. Oncol. 24 : 4270 4276.
9. Wang, B.G. et al. 2003. Increased plasma DNA integrity in cancer patients. Cancer Res. 63 : 3966 3968.
10. Page, K. et al. 2006. The importance of careful blood processing in isolation of cell-free DNA. Ann. N. Y. Acad. Sci. 1075 : 313 317.
11. Schmidt, B. et al. 2005. Improved method for isolating cell-free DNA. Clin. Chem. 51 : 1561 1563.
12. Wang, M. et al. 2004. Preferential isolation of fragmented DNA enhances the detection of circulating mutated k-ras DNA. Clin. Chem. 50 : 211 213.
13. de Kok, J.B. et al. 1998. Use of real-time quantitative PCR to compare DNA isolation methods. Clin. Chem. 44 : 2201 2204.
14. Dixon, S.C. et al. 1998. Methods for extracting and amplifying genomic DNA isolated from frozen serum. Nat. Biotechnol. 16 : 91 94.
15. Clausen, F.B. et al. 2007. Improvement in fetal DNA extraction from maternal plasma: evaluation of the NucliSens Magnetic Extraction system and the QIAamp DSP Virus Kit in comparison with the QIAamp DNA Blood Mini Kit. Prenat. Diagn. 27 : 6 10.
16. Lee, T.H. et al. 2001. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41 : 276 282.
17. Jung, M. et al. 2003. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin. Chem. 49 : 1028 1029.
18. Taback, B., S.J. O'Day & D.S. Hoon. 2004. Quantification of circulating DNA in the plasma and serum of cancer patients. Ann. N. Y. Acad. Sci. 1022 : 17 24.
19. Daniotti, M. et al. 2007. Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients. Int. J. Cancer 120 : 2439 2444.
20. Sozzi, G. et al. 2001. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 61 : 4675 4678.
21. Sozzi, G. et al. 2003. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J. Clin. Oncol. 21 : 3902 3908.
22. Beau-Faller, M. et al. 2003. Plasma DNA microsatellite panel as sensitive and tumor-specific marker in lung cancer patients. Int. J. Cancer 105 : 361 370.
23. Chen, L. et al. 2005. Biomarkers for small cell lung cancer (SCLC): DNA methylation and GD2 synthase transcript levels. Lung Cancer 49 (Suppl 2 S316.
24. Jiang, W.W. et al. 2006. Increased plasma DNA integrity index in head and neck cancer patients. Int. J. Cancer 119 : 2673 2676.
25. Umetani, N. et al. 2006. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin. Chem. 52 : 1062 1069.